Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel stannous chloride reduction method for lenalidomide N-hydroxy impurity ensures high purity and supply chain stability for pharmaceutical quality control standards.
Novel 5-step synthesis for biaryl quinolin derivatives. High yield, purified process. Reliable pharmaceutical intermediates supplier for TB drug development.
Patent CN102002016A details a safer Febuxostat synthesis avoiding toxic cyanating agents. Discover cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN1041632C details a high-yield acyclovir process minimizing 7-isomer impurities. Discover cost-effective antiviral manufacturing solutions.
Patent CN112279776B reveals a safer, telescoped synthesis for arformoterol free base, eliminating column chromatography and reducing production costs significantly.
Novel metal-free synthesis of 3-nitroquinoline derivatives with high yield. Ideal for anti-tumor drug development. Cost-effective scale-up solutions available.
Novel six-step synthesis for ATDE-Cl side chain achieving high purity above 93%. Cost-effective scalable route for pharmaceutical intermediates ensures supply chain reliability.
Patent CN111747879A details a scalable Erexib synthesis using mild reagents. Discover cost-effective manufacturing and high-purity pharmaceutical intermediates.
Novel DMAP catalyzed process improves yield and purity for pharmaceutical intermediates supply chain efficiency and commercial scalability.
Patent CN104293848A reveals high-yield biocatalytic route for chiral intermediates. Offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Patent CN105829335B reveals stereoselective synthesis improving purity. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN101851195B details a novel 11-step quinoline synthesis for camptothecin. Discover cost-effective routes and high-purity intermediates for API manufacturing.
Patent CN102491994B details a novel preparation method for phosphocholine alkyl ester ensuring high purity and simplified purification for reliable pharmaceutical intermediates supply chain efficiency.
Patent CN103265616B details a stable N(2)-Ala-Gln synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN102775345A reveals a novel route for Roflumilast intermediates, offering high purity and cost-effective manufacturing for global pharmaceutical supply chains.
Patent CN103102324A details a novel Leucogen synthesis eliminating methyl ester impurities. Discover cost-effective, scalable pharmaceutical intermediate manufacturing solutions.
Discover the patented synthesis of 2-(2-thienyl) ethanol p-toluenesulfonate. A robust, high-yield route for pharmaceutical intermediates ensuring supply chain stability.
Patent CN109305977B reveals a safer double-oxidation route for Tazobactam. Enhance supply chain stability and reduce manufacturing risks with this novel process.
Patent CN101501000B details a novel purification process for Montelukast using chiral amine salts, offering high optical purity and cost reduction in pharmaceutical intermediate manufacturing without chromatography.
Novel palladium-catalyzed route reduces costs and improves purity for Telmisartan manufacturing supply chain stability and commercial scalability for global buyers.